# R30 External Audit Result - 20260709

Batch: `WINDOWS_WSL2_STRATEGY_FACTORY_R30_20260709`

## Verdict

`ACCEPT_WITH_FIXES_BEFORE_PROBE`

## External audit trigger

`no` for production / route / readiness / trading activation.

## Fixes required

Before any local research probe task can run, R31 must validate `liquidity_constrained_reversal` without using test outcomes for selection.

Reason: R30's pre-registered eligibility rule included test spread and test IC. This is acceptable as hypothesis-generation evidence, but insufficient for immediate local-probe execution.

## Accepted scope

- R30 processed active surfaces first.
- SmallCap was stopped because direct market-cap evidence remained unavailable.
- US30W remained observation-only.
- pass77 old repair reruns remained source-gated.
- ETF rotation remained retired.
- Six new local/pass77 strategy families were pre-registered before evaluation.
- `liquidity_constrained_reversal` was the only line with positive train/validation/test spread and validation/test IC under the R30 pre-registered rule.
- `strategy_candidate_available=false`.

## Rejected or blocked scope

- R30 `LOCAL_RESEARCH_PROBE_ELIGIBLE` cannot be used directly for probe execution until R31 revalidates with validation-only selection and test diagnostic-only handling.
- No strategy candidate, recommendation, readiness, product route, daily signal, or trading path is created.

## Boundary result

Research-only boundary preserved. No actionable output, recommendation/advice, ticket, candidate promotion, readiness/product-route/registry activation, daily signal, broker/order/paper/live/auto path, raw-data migration, active schema change, full-frame wide3068, secret output, or parameter tuning from test results occurred.

## Next batch

`WINDOWS_WSL2_LIQUIDITY_REVERSAL_LOCAL_PROBE_VALIDATION_R31_20260709`

R31 must treat R30 as hypothesis-generation evidence and revalidate `liquidity_constrained_reversal` under validation-only selection rules before any local research probe execution.
